Literature DB >> 26048994

RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.

Margaret Lee1, Peter Gibbs2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26048994      PMCID: PMC4609554          DOI: 10.1093/jnci/djv149

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Authors:  Kimmie Ng; Jeffrey A Meyerhardt; Andrew T Chan; Kaori Sato; Jennifer A Chan; Donna Niedzwiecki; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Alan P Venook; Shuji Ogino; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2014-11-27       Impact factor: 13.506

2.  Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

Authors:  Rachel S Midgley; Christopher C McConkey; Elaine C Johnstone; Janet A Dunn; Justine L Smith; Simon A Grumett; Patrick Julier; Claire Iveson; Yoko Yanagisawa; Bryan Warren; Michael J Langman; David J Kerr
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

3.  Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

Authors:  Xiaoyun Liao; Paul Lochhead; Reiko Nishihara; Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Yu Imamura; Zhi Rong Qian; Yoshifumi Baba; Kaori Shima; Ruifang Sun; Katsuhiko Nosho; Jeffrey A Meyerhardt; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

Review 4.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Authors:  Enrico Flossmann; Peter M Rothwell
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

5.  Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

Authors:  Marlies S Reimers; Esther Bastiaannet; Ruth E Langley; Ronald van Eijk; Ronald L P van Vlierberghe; Valery E P Lemmens; Myrthe P P van Herk-Sukel; Tom van Wezel; Riccardo Fodde; Peter J K Kuppen; Hans Morreau; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.